Erlotinib for Pancreatic Cancer User Reviews

Erlotinib has an average rating of 5.7 out of 10 from a total of 3 reviews for the treatment of Pancreatic Cancer. 33% of reviewers reported a positive experience, while 33% reported a negative experience.

Erlotinib rating summary

5.7/10 average rating

3 ratings from 3 user reviews.

Compare all 25 medications used in the treatment of Pancreatic Cancer.

10		33%
9		0%
8		0%
7		0%
6		0%
5		33%
4		0%
3		0%
2		33%
1		0%

suebie
March 13, 2009

"My husband didn't live long enough to tell the effectiveness on his stage 4B Pancreatic Cancer. Passed away 2 days after 1st chemo with gemcitibine and erlotinib. No immediate side effects, easy to take."

5 / 10

Was this helpful?Yes No

1 Report

Soly
Taken for less than 1 month
January 26, 2021

Tarceva (erlotinib) "I have Pancreatic head Cancer since July 2016 was stage 4 so palliative bypass was done, then put on chemo several times. 3 months back my CT showed progression for the 1st time rather than regression so my doctor put me on Tarceva 100mg. Unfortunately, I felt more weakness, anorexia, skin rash, nausea, belching plus much increase in pains in my tummy and back. I don't know what to say...??!"

2 / 10

Was this helpful?Yes No

0 Report

Laura
Taken for 2 to 5 years
October 12, 2020

Tarceva (erlotinib) "This drug Tarceva has helped keep me alive for last 3 years. Have pancreatic cancer."

10 / 10

Was this helpful?Yes No

2 Report

Frequently asked questions

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.